Briacell Therapeutics
Price & Volume
Stats
See more52W Range | $3.60-$39.50 |
Market Cap | $30.3M |
Shares Short | 227,052 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$14.42 |
News
See moreYahoo Finance • 2 months ago
BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference
Yahoo Finance • 4 months ago
“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine
Yahoo Finance • 5 months ago
BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout
Yahoo Finance • 5 months ago
BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025
About
CEO | Dr. William V. Williams FCPA, M.D. |
CFO | Mr. Gadi Levin B.Com., C.A., CPA, M.B.A. |
Address | Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |